at www.tipranks.com (Fri, 6-Nov 9:07 AM)
Avalo Therapeutics: Neutral Amid Strong Cash Position and Significant Clinical Uncertainty
at www.tipranks.com (Fri, 6-Nov 9:01 AM)
Bank of America Securities Sticks to Their Buy Rating for Avalo Therapeutics (AVTX)
at www.tipranks.com (Fri, 6-Nov 7:58 AM)
Avalo Therapeutics Enters New $200 Million Stock Sales Agreement
at www.tipranks.com (Thu, 5-Nov 8:51 AM)
Avalo Therapeutics GAAP EPS of -$0.34 beats by $0.27
at seekingalpha.com (Thu, 5-Nov 7:43 AM)
